News

Aliveness Project to offer newly approved, first-of-its-kind HIV prevention treatment
The first of its kind to be approved by the FDA, the twice-yearly shot lenacapavir reportedly nearly eliminated new ...
Public Broadcasting Service (PBS)2d
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
KESQ2h
Living Healthy: HIV clinics brace for uncertainty as Congress weighs spending bill, medicaid cuts
As Congress finalizes a sweeping new federal spending bill, healthcare providers are sounding the alarm over what could be at ...
FDA approves twice-a-year injection for HIV prevention
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
The Nation Online14h
HIV prevention jab gets approval
National Aids Commission (NAC) and health campaigners have welcomed the approval of a twice-a-year HIV prevention injection ...
The FDA Just Approved a Long-Lasting Injection to Prevent HIV
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
HIV prevention drug lenacapavir approved by FDA as twice-yearly injection
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
The American Journal of Managed Care4d
Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA
The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...
U.S. approves first-ever biannual shot to prevent HIV, but getting it might be hard
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The Week1d
HIV prevention drug lenacapavir gets FDA nod, nearly 100 per cent effective says experts
HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...
A new HIV drug promises 99.9% protection. But it's making Indian health activists wary; Why?
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...